MRSA and osteomyelitis of the foot in diabetes

Diabetic Medicine, Supplement

Volumn 21, Issue 4, 2004, Pages 16-19

  Game, F ^a   Jeffcoate, W ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; DOXYCYCLINE; FLUCLOXACILLIN; FUSIDIC ACID; GLICLAZIDE; LINEZOLID; METFORMIN; RAMIPRIL; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BLOOD CULTURE; BONE BIOPSY; COUNSELING; DEBRIDEMENT; DIABETIC FOOT; DIFFERENTIAL DIAGNOSIS; FOOT ULCER; HUMAN; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHROPATHY; OSTEOMYELITIS; PATIENT COMPLIANCE; REVIEW; X RAY;

EID: 4544274452     PISSN: 14665468     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.1424-8.x     Document Type: Review

References (15)

1. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. JAMA 1995; 273: 721-723.
2. Jeffcoate WJ, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 2004; in press.
3. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997; 25: 1318-1326.
4. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ, Hermann G et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosisng and monitoring by leukocyte scanning with indium in 111 oxyquinolone. JAMA 1991; 266: 1246-1251.
5. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22: 157-162.
6. Adler EI, Boyko EJ, Ahroni JH, Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999; 22: 1029-1035.
7. Murdoch DP, Armstrong DG, Dacus JB, Laughlin TJ, Morgan CB, Lavery LA. The natural history of great toe amputations. J Foot Ankle Surg 1997; 36: 204-208.
8. Nehler MR, Whitehill TA, Bowers SP, Jones DN, Hiatt WR, Ritherford RB et al. Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalisation and presumed adequate circulatory status. J Vasc Surg 1999; 30: 509-517.
9. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Johnson SK et al. Comparison of community- and health care-associated methicillin resistant Staphylococcus aureus infection. JAMA 2003; 290: 2976-2984.
10. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359: 1791-1792.
11. Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJ. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 1999; 16: 767-771.
12. Game FL, Boswell T, Soar C, Houghton E, Treece K, Pound N, Jeffcoate WJ. Outcome in diabetic foot ulcers with and without methicillin resistant Staphylococcus aureus (MRSA). Diabet Med 2003; 20(Suppl 2): 30.
13. Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, Grimaldi A. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med 2004; 21: 710-715.
14. Wagner A, Reike H, Angelkort B. Highly resistant pathogens in patients with diabetic foot syndrome with reference to methicillin-resistant Staphylococcus aureus infections. Dtsch Med Wochenschr 2001; 126: 1353-1356.
15. Freel EM, Bell E, Seaton A, Jones GC. Out-patient and home antibiotic therapy (OPHAT) is an effective and cost efficient alternative to in-patient treatment of diabetic foot osteomyelitis. Diabet Med 2003; 20: 91.